Integrated analysis of microfibrillar-associated proteins reveals MFAP4 as a novel biomarker in human cancers-Reference-Cited by-同舟云学术

Integrated analysis of microfibrillar-associated proteins reveals MFAP4 as a novel biomarker in human cancers

Published:2019-01 Issue:1 Volume:11 Page:5-21
ISSN:1750-1911
Container-title:Epigenomics
language:en
Short-container-title:Epigenomics

Author:

Yang Jue¹²,Song Hui³⁴,Chen Li⁵,Cao Kun⁶,Zhang Yongqiang⁷,Li Yanmei¹²,Hao Xiaojiang¹²

Affiliation:

1. The State Key Laboratory of Functions & Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, PR China

2. The Key Laboratory of Chemistry for Natural Products of Guizhou Province & Chinese Academic of Sciences, Guiyang 550014, PR China

3. The Key Laboratory of Endemic & Ethnic Diseases, Guizhou Medical University, Ministry of Education, Guiyang 550004, PR China

4. The Key Laboratory of Medical Molecular Biology, Guizhou Medical University, Guizhou Province, Guiyang 550004, PR China

5. Guiyang University of Chinese Medicine, School of Pharmaceutical Sciences, Guiyang 550025, PR China

6. Department of General Surgery, Affiliated Hospital of Guizhou Medical University, Guiyang 550001, PR China

7. Guizhou University, School of Pharmaceutical Sciences, Guiyang, 550025, PR China

Abstract

Aim: The potential functions and underlying mechanism of microfibrillar-associated proteins (MFAPs) are explored in human cancers. Materials & methods: Here, we examined the expression profiles, prognostic values, epigenetic and genetic alterations of MFAPs in human cancers from public omics repository. Results: Among MFAPs family, MFAP4 was frequently downregulated in the most human cancers and high mRNA expression of MFAP4 significantly correlated with better overall survival in breast cancer. DNA hypermethylation in the promoter of MFAP4 decreased its mRNA expression. MFAP4 strongly associated with pathway in impairment and alteration of the elastic fibers. Conclusion: This integrated analysis provides new insights into MFAPs in human cancers and indicates that MFAP4 could be used as novel biomarker for developing therapies against human cancers.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Genetics

Link

https://www.futuremedicine.com/doi/pdf/10.2217/epi-2018-0080

Reference62 articles.

1. Basic Components of Connective Tissues and Extracellular Matrix: Elastin, Fibrillin, Fibulins, Fibrinogen, Fibronectin, Laminin, Tenascins and Thrombospondins

2. Structural disorder and dynamics of elastinThis paper is one of a selection of papers published in this special issue entitled “Canadian Society of Biochemistry, Molecular & Cellular Biology 52nd Annual Meeting — Protein Folding: Principles and Diseases” and has undergone the Journal's usual peer review process.

3. Elastic fibres in health and disease

4. The microfibril-associated glycoproteins (MAGPs) and the microfibrillar niche

5. Microfibril-associated Protein 4 Is Present in Lung Washings and Binds to the Collagen Region of Lung Surfactant Protein D

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Competing endogenous RNAs regulatory crosstalk networks: The messages from the RNA world to signaling pathways directing cancer stem cell development;Heliyon;2024-08

2. Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer;Frontiers in Immunology;2024-01-03

3. PathExpSurv: pathway expansion for explainable survival analysis and disease gene discovery;BMC Bioinformatics;2023-11-15

4. Phase-specific signatures of wound fibroblasts and matrix patterns define cancer-associated fibroblast subtypes;Matrix Biology;2023-05

5. Declined plasma microfibrillar-associated protein 4 levels in acute coronary syndrome;European Journal of Medical Research;2023-01-18